NYLI Candriam U.S. Mid Cap Equity ETF (IQSM)

Assets	$316.20M
Expense Ratio	0.15%
PE Ratio	21.54
Shares Out	8.48M
Dividend (ttm)	$0.41
Dividend Yield	1.10%
Ex-Dividend Date	Mar 20, 2026
Payout Frequency	Quarterly
Payout Ratio	23.58%

Volume	1,344
Open	37.19
Previous Close	37.31
Day's Range	37.17 - 37.21
52-Week Low	29.74
52-Week High	37.64
Beta	1.17
Holdings	243
Inception Date	Oct 25, 2022

About IQSM

Fund Home Page

The NYLI Candriam U.S. Mid Cap Equity ETF (IQSM) is an exchange-traded fund that is based on the NYLI Candriam U.S. Mid Cap Equity index. The fund tracks a market cap-weighted index that provides exposure to US mid-cap stocks that meet environmental, social, and corporate governance criteria. IQSM was launched on Oct 25, 2022 and is issued by New York Life Investments.

• Asset Class: Equity
• Category: Mid-Cap Blend
• Region: North America
• Stock Exchange: NYSEARCA
• Ticker Symbol: IQSM
• ETF Provider: New York Life Investments
• Index Tracked: NYLI Candriam U.S. Mid Cap Equity Index

Top 10 Holdings

10.36% of assets

Name	Symbol	Weight
TechnipFMC plc	FTI	1.29%
Fabrinet	FN	1.19%
XPO, Inc.	XPO	1.11%
United Therapeutics Corporation	UTHR	1.04%
MasTec, Inc.	MTZ	1.04%
Revolution Medicines, Inc.	RVMD	1.03%
nVent Electric plc	NVT	0.98%
Albemarle Corporation	ALB	0.94%
C.H. Robinson Worldwide, Inc.	CHRW	0.87%
Burlington Stores, Inc.	BURL	0.87%

Dividend History

Ex-Dividend	Amount	Pay Date
Mar 20, 2026	$0.08137	Mar 24, 2026
Dec 19, 2025	$0.1262	Dec 26, 2025
Sep 19, 2025	$0.10566	Sep 25, 2025
Jun 20, 2025	$0.09509	Jun 26, 2025
Mar 21, 2025	$0.08091	Mar 27, 2025
Dec 20, 2024	$0.13287	Dec 26, 2024

Performance

IQSM had a total return of 27.33% in the past year, including dividends. Since the fund's inception, the average annual return has been 12.36%.